233 related articles for article (PubMed ID: 35977796)
21. The p150 Isoform of ADAR1 Blocks Sustained RLR signaling and Apoptosis during Influenza Virus Infection.
Vogel OA; Han J; Liang CY; Manicassamy S; Perez JT; Manicassamy B
PLoS Pathog; 2020 Sep; 16(9):e1008842. PubMed ID: 32898178
[TBL] [Abstract][Full Text] [Related]
22. Identification of ADAR1 p150 and p110 Associated Edit Sites.
Sun T; Rosenberg BR; Chung H; Rice CM
Methods Mol Biol; 2023; 2651():285-294. PubMed ID: 36892775
[TBL] [Abstract][Full Text] [Related]
23. ADAR1-mediated RNA editing is required for thymic self-tolerance and inhibition of autoimmunity.
Nakahama T; Kato Y; Kim JI; Vongpipatana T; Suzuki Y; Walkley CR; Kawahara Y
EMBO Rep; 2018 Dec; 19(12):. PubMed ID: 30361393
[TBL] [Abstract][Full Text] [Related]
24. Identification and characterization of a constitutively expressed Ctenopharyngodon idella ADAR1 splicing isoform (CiADAR1a).
Liu X; Huang K; Hou Q; Sun Z; Wang B; Lin G; Li D; Liu Y; Xu X; Hu C
Dev Comp Immunol; 2016 Oct; 63():10-7. PubMed ID: 27185203
[TBL] [Abstract][Full Text] [Related]
25. Extensive editing of cellular and viral double-stranded RNA structures accounts for innate immunity suppression and the proviral activity of ADAR1p150.
Pfaller CK; Donohue RC; Nersisyan S; Brodsky L; Cattaneo R
PLoS Biol; 2018 Nov; 16(11):e2006577. PubMed ID: 30496178
[TBL] [Abstract][Full Text] [Related]
26. Mutations in the adenosine deaminase ADAR1 that prevent endogenous Z-RNA binding induce Aicardi-Goutières-syndrome-like encephalopathy.
Nakahama T; Kato Y; Shibuya T; Inoue M; Kim JI; Vongpipatana T; Todo H; Xing Y; Kawahara Y
Immunity; 2021 Sep; 54(9):1976-1988.e7. PubMed ID: 34525338
[TBL] [Abstract][Full Text] [Related]
27. The RNA-editing enzyme ADAR1 controls innate immune responses to RNA.
Mannion NM; Greenwood SM; Young R; Cox S; Brindle J; Read D; Nellåker C; Vesely C; Ponting CP; McLaughlin PJ; Jantsch MF; Dorin J; Adams IR; Scadden AD; Ohman M; Keegan LP; O'Connell MA
Cell Rep; 2014 Nov; 9(4):1482-94. PubMed ID: 25456137
[TBL] [Abstract][Full Text] [Related]
28. Isoforms of RNA-Editing Enzyme ADAR1 Independently Control Nucleic Acid Sensor MDA5-Driven Autoimmunity and Multi-organ Development.
Pestal K; Funk CC; Snyder JM; Price ND; Treuting PM; Stetson DB
Immunity; 2015 Nov; 43(5):933-44. PubMed ID: 26588779
[TBL] [Abstract][Full Text] [Related]
29. ADAR regulates APOL1 via A-to-I RNA editing by inhibition of MDA5 activation in a paradoxical biological circuit.
Riella CV; McNulty M; Ribas GT; Tattersfield CF; Perez-Gill C; Eichinger F; Kelly J; Chun J; Subramanian B; Guizelini D; ; Alper SL; Pollak MR; Sampson MG; Friedman DJ
Proc Natl Acad Sci U S A; 2022 Nov; 119(44):e2210150119. PubMed ID: 36282916
[No Abstract] [Full Text] [Related]
30. Adenosine deaminase acting on RNA-1 (ADAR1) inhibits hepatitis B virus (HBV) replication by enhancing microRNA-122 processing.
Liu G; Ma X; Wang Z; Wakae K; Yuan Y; He Z; Yoshiyama H; Iizasa H; Zhang H; Matsuda M; Sugiyama R; Yuan Z; Muramatsu M; Li L
J Biol Chem; 2019 Sep; 294(38):14043-14054. PubMed ID: 31366735
[TBL] [Abstract][Full Text] [Related]
31. Adenosine-to-inosine editing of endogenous Z-form RNA by the deaminase ADAR1 prevents spontaneous MAVS-dependent type I interferon responses.
Tang Q; Rigby RE; Young GR; Hvidt AK; Davis T; Tan TK; Bridgeman A; Townsend AR; Kassiotis G; Rehwinkel J
Immunity; 2021 Sep; 54(9):1961-1975.e5. PubMed ID: 34525337
[TBL] [Abstract][Full Text] [Related]
32. Adenosine Deaminases Acting on RNA (ADARs) and Viral Infections.
Pfaller CK; George CX; Samuel CE
Annu Rev Virol; 2021 Sep; 8(1):239-264. PubMed ID: 33882257
[TBL] [Abstract][Full Text] [Related]
33. Induction of Viral Mimicry Upon Loss of DHX9 and ADAR1 in Breast Cancer Cells.
Cottrell KA; Ryu S; Pierce JR; Soto Torres L; Bohlin HE; Schab AM; Weber JD
Cancer Res Commun; 2024 Apr; 4(4):986-1003. PubMed ID: 38530197
[TBL] [Abstract][Full Text] [Related]
34. Adenosine-Deaminase-Acting-on-RNA-1 Facilitates T-cell Migration toward Human Melanoma Cells.
Margolis N; Moalem H; Meirson T; Galore-Haskel G; Markovits E; Baruch EN; Vizel B; Yeffet A; Kanterman-Rifman J; Debby A; Besser MJ; Schachter J; Markel G
Cancer Immunol Res; 2022 Sep; 10(9):1127-1140. PubMed ID: 35731225
[TBL] [Abstract][Full Text] [Related]
35. Adenosine Deaminase Acting on RNA 1 Associates with Orf Virus OV20.0 and Enhances Viral Replication.
Liao GR; Tseng YY; Tseng CY; Lin FY; Yamada Y; Liu HP; Kuan CY; Hsu WL
J Virol; 2019 Apr; 93(7):. PubMed ID: 30651363
[TBL] [Abstract][Full Text] [Related]
36. Adenosine Deaminase Acting on RNA (ADAR) Enzymes: A Journey from Weird to Wondrous.
Keegan LP; Hajji K; O'Connell MA
Acc Chem Res; 2023 Nov; 56(22):3165-3174. PubMed ID: 37906879
[TBL] [Abstract][Full Text] [Related]
37. Vaccinia virus E3L interferon resistance protein inhibits the interferon-induced adenosine deaminase A-to-I editing activity.
Liu Y; Wolff KC; Jacobs BL; Samuel CE
Virology; 2001 Oct; 289(2):378-87. PubMed ID: 11689059
[TBL] [Abstract][Full Text] [Related]
38. Altered A-to-I RNA editing in human embryogenesis.
Shtrichman R; Germanguz I; Mandel R; Ziskind A; Nahor I; Safran M; Osenberg S; Sherf O; Rechavi G; Itskovitz-Eldor J
PLoS One; 2012; 7(7):e41576. PubMed ID: 22859999
[TBL] [Abstract][Full Text] [Related]
39. What do editors do? Understanding the physiological functions of A-to-I RNA editing by adenosine deaminase acting on RNAs.
Heraud-Farlow JE; Walkley CR
Open Biol; 2020 Jul; 10(7):200085. PubMed ID: 32603639
[TBL] [Abstract][Full Text] [Related]
40. The role of RNA editing enzyme ADAR1 in human disease.
Song B; Shiromoto Y; Minakuchi M; Nishikura K
Wiley Interdiscip Rev RNA; 2022 Jan; 13(1):e1665. PubMed ID: 34105255
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
